beta

ADCT

ADC Therapeutics SA

Chart

Stats

Earnings

News

Splits

Dividends

Earnings

Actual EPS
Consensus EPS
Estimated EPS
Number of Estimates
EPS Surprise

Stats

Summary

ADC Therapeutics SA is a clinical-stage biotechnology company, which develops antibody drug conjugates. Its products include Lonca, Cami and ADCT-602. Its drugs are used in treating various advanced solid tumors. The company was founded on June 6, 2011 and is headquartered in Epalinges, Switzerland.

Market Cap: 2.54 Billion

Primary Exchange: New York Stock Exchange

Website: http://www.adctherapeutics.com

Shares Outstanding: 68.9 Million

Float: 33.4 Million

Dividend: (%)

Beta: 1.47779765662962

Sector: Health Technology

Industry: Pharmaceuticals: Major

Ethical Flags

Longest drawdown: 3 trading days

From: 2020-05-28 To: 2020-06-02

Lowest Point:

Ex-Date Payment Date Record Date Declared Date Amount Flag Dividend Type Qualified Indicated
Ex-Date Declared Date Record Date Payment Date Ratio To Factor For Factor
Data provided by IEX Cloud